How we got a glut of grade 9s in GCSE English He predicted none he hoped for a couple but in the end 14 of Mark Roberts students got the top grade for GCSE English How did they do it He reveals all Last year we predicted zero grade 9s in GCSE English for our students This new grade was basically going to be an A on anabolic steroids something only for the crème de la crème the top 2 per cent of GCSE English students in the country But secretly we hoped wed get a couple We ended up with 14 Most pleasingly we had an equal gender split the national picture saw twothirds of the top grades awarded to girls So how did it happen A challenging key stage 3 curriculum When I arrived at the school four years ago the key stage 3 emphasis was on engagement through fun card sorts pupils moving around tables texts chosen for their accessibility And now Gripping but complex novels Shakespeare done properly radical ideas like using his actual language and classic poetry Lots of opportunities to practise extended writing The result Greater productivity greater quality of work and students are no longer bamboozled by the step up to GCSE English A faculty ethos We spend a lot of time in faculty meetings working on subject knowledge We all do the same books We all teach the same topics at the same time with each year group This means lots of discussion and sharing of ideas Rigorous assessment Grade boundaries which were complete guesswork were set high The focus was on avoiding complacency and emphasising consistent improvement not obsessing over target grades and mark schemes We crossmarked each endofunit assessments and mock exam If in doubt we marked harshly The papers we set were slightly more challenging than exam board specimens Pupils came out of the real thing saying the papers were easier than expected I didnt have the budget to get many papers back but I did splash out on copies of as many of the grade 9s as possible This is what I found in the pupils texts Deep knowledge of the text We spend a lot of time on the literature texts No scenes are skipped Using memory platforms we test knowledge of key quotes themes ideas characters and context regularly We space and interleave to revisit texts that pupils havent encountered recently As a result those that achieved grade 9s knew the texts like the back of their writing hand They knew structural patterns They coped with an obscure extract being chosen for the exam AQAs Romeo Juliet question They didnt make silly factual errors Seamless links between context and language Instead of generalised statements about what happened in those days social historical and cultural context was used to illuminate the writers word choice Grade 9 pupils had a nuanced appreciation of the influence of Darwinism on Robert Louis Stevensons description of Mr Hyde They used autobiographical detail carefully Significantly they were often able to place the particular text within the context of the writers oeuvre for example applying their knowledge of Macbeth to gain a sophisticated understanding of Romeo Juliet Subtle understanding of gender The GCSE English canon may well be too pale too stale and too male but our highestachieving pupils grasped the opportunity to show a mature understanding of the role of gender inequality over the centuries This went beyond vague comments on patriarchy and grappled with the complexities of gender dynamics such as Romeos lament O sweet Juliet Thy beauty hath made me effeminate Use of evaluative verbs Many pupils and teachers have found the English language evaluation questions the most challenging aspect of the new GCSE English specifications But the most successful pupils evaluate consistently whether or not the question prompts them Our highest attainers analysed how a writer ridicules trivialises demonises or how a character coerces sentimentalises or derides another Interpretations show originality and plausibility Pupils who are encouraged to make perceptive comments when analysing language often stretch original ideas beyond breaking point It can be disheartening for a bright pupil to be told that an inventive interpretation is just plain wrong but thats something we do The best answers Ive seen spend more time dissecting ambiguity in language rather than making outlandish attempts at breathtaking originality Use of sophisticated terminology with precise explanation of effect Anyone whos read the examiners reports or has been on an exam board feedback course will know that sophisticated terminology has taken a kicking The advice has been dont teach it to your pupils looking up fancy Greek words just annoys the examiners Save it for A level Pupils end up feature spotting and never get good marks for it The evidence from our returned scripts we are very much in the minority suggests otherwise If taught well with an absolute insistence on exploring effect the rewards are high Ive seen pupils gain impressive marks for their clear comments on the effect of the following terms antithesis liminality analepsis anadiplosis and verisimilitude Confident use of structural devices in the writing sections Of course we saw fluently crafted sentences and complex punctuation for effect Ambitious vocabulary was judiciously and selectively chosen But what stood out the most was how grade 9 pupils employed the structural devices theyd learned for the reading questions in their own writing The time spent on complex repetition narrative theory and paragraph cohesion paid off And yet we may have been fortunate We may have lucked out with an exceptional crop of pupils We may see our results drop this summer and our grade 9s dwindle The exam board may bare its teeth and raise its grade boundaries Still Im hopeful well achieve the same number of top grades this year At the risk of hubris we might even do better With an extra year of teaching the specification under our belt we feel more confident The pupils are working hard and seem increasingly ready and if you have a different grade 9 story to tell Id very much like to hear it Mark Roberts is an assistant headteacher at a secondary school in the South West of England Attainment Exams and assessment GCSE Breaking views School news

O O O O O O B I O B I O O O O O O O O O O O O O O O O O O O O O O B I O O O O O O O O O O O O O B I O B I O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B I O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B I O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B I O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B I O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B I O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B I O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B I O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O


Gmatgre Essays Essay topics In any field of endeavor it is impossible to make a significant contribution without first being strongly influenced by past achievements within that field Write a response in which you discuss the extent to which you agree or disagree with the statement and explain your reasoning for the position you take In developing and supporting your position you should consider ways in which the statement might or might not hold true and explain how these considerations shape your position Submitted by hossein021 on Sat 10052013 0654 By reviewing the past history of humans life it will be revealed that they have shown significant performance which has led to make some impossible situations to possible ones moreover human races has been always trying to use the previous experiences of their ancestors to achive progresses in some field of endeavor in fact the humanity has a kind of limitation in these experiences hence just can use of some of them not all In the statement has been mentioned that it is impossible for the mankind gain improvement in any field of endeavor which is in a contradict with some fields of study for instance the areospace technology and knowledge almost a new technology which might have an age around fifty years Before the first journey of human to the moon there were not any previous achivement in this field and even this technology would never come to the mind of our ancestors but after that NASA could land its first spacecraft on the moon the new science of areospace was established Or In addition in the statement has been mentioned that in all field of endeavor it is impossible that reach to achivement however as it was mentioned in the previous paragraph just in few fields such as aerospace nuclear power and Nano can not use of previous achivements On the contrary there is a positive side that human could use of it such as airplains trains cars and etc Wrights brothers were constructed the first type of plains which has no motor but they could fly with it After passing times this invention was improved and progressed but the fundamentals and As a summary the humanity has shown that is capable to change impossible parts of the life to possible facets while there is no previous experience about it on the other hand heshe could utilize previous experience to progress some field of study Essay Categories GMATGRE Votes Cancel rating Give In any field of endeavor it is impossible to make a significant contribution without first being strongly influenced by past achievements within that fieldWrite a response in which you discuss the extent to which you agree or disagree with the statement 110 Give In any field of endeavor it is impossible to make a significant contribution without first being strongly influenced by past achievements within that fieldWrite a response in which you discuss the extent to which you agree or disagree with the statement 210 Give In any field of endeavor it is impossible to make a significant contribution without first being strongly influenced by past achievements within that fieldWrite a response in which you discuss the extent to which you agree or disagree with the statement 310 Give In any field of endeavor it is impossible to make a significant contribution without first being strongly influenced by past achievements within that fieldWrite a response in which you discuss the extent to which you agree or disagree with the statement 410 Give In any field of endeavor it is impossible to make a significant contribution without first being strongly influenced by past achievements within that fieldWrite a response in which you discuss the extent to which you agree or disagree with the statement 510 Give In any field of endeavor it is impossible to make a significant contribution without first being strongly influenced by past achievements within that fieldWrite a response in which you discuss the extent to which you agree or disagree with the statement 610 Give In any field of endeavor it is impossible to make a significant contribution without first being strongly influenced by past achievements within that fieldWrite a response in which you discuss the extent to which you agree or disagree with the statement 710 Give In any field of endeavor it is impossible to make a significant contribution without first being strongly influenced by past achievements within that fieldWrite a response in which you discuss the extent to which you agree or disagree with the statement 810 Give In any field of endeavor it is impossible to make a significant contribution without first being strongly influenced by past achievements within that fieldWrite a response in which you discuss the extent to which you agree or disagree with the statement 910 Give In any field of endeavor it is impossible to make a significant contribution without first being strongly influenced by past achievements within that fieldWrite a response in which you discuss the extent to which you agree or disagree with the statement 1010 Average 71 35 votes or register to post comments This essay topic by other users 3 days 13 hours ago evanlu 54 Read full essay 1 week 2 days ago sarathcmr 33 Read full essay 3 weeks 9 hours ago satyamverma95g 50 Read full essay 3 weeks 3 days ago tb9665 50 Read full essay 1 month 3 weeks ago Dipendra 50 Read full essay 1 month 3 weeks ago Dipendra 50 Read full essay 2 months 1 week ago Saud 50 Read full essay 2 months 1 week ago PRASHNATI15 50 Read full essay 2 months 1 week ago rajat125009 50 Read full essay 3 months 1 week ago akshaymanjunath 75 Read full essay 1 2 3 4 5 last

O O B I O O O O O O O O O O O B I O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B I O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B I O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B I O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B I O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B I O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B I O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B I O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B I O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B I O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B I O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O


Teva

Launches

AirDuo

RespiClick

and

its

Authorized

Generic

Two

Inhalers

Containing

Fluticasone

Propionate

and

Salmeterol

First

and

Only

Generic

Fluticasone

Propionate

and

Salmeterol

ICSLABA

Inhaler

Available

in

the

US

JERUSALEM

BUSINESS

WIREApr

Teva

Pharmaceutical

Industries

Ltd

NYSE

and

TASETEVA

today

announced

the

simultaneous

launch

of

AirDuo

RespiClick

fluticasone

propionate

and

salmeterol

inhalation

powder

and

its

authorized

generic

for

the

treatment

of

asthma

in

patients

aged

years

and

older

who

are

uncontrolled

on

an

inhaled

corticosteroid

ICS

or

whose

disease

severity

clearly

warrants

the

use

of

an

ICSlongacting

beta

adrenergic

agonist

LABA

combination

AirDuo

RespiClick

and

its

authorized

generic

are

fixeddose

combination

asthma

therapies

containing

an

ICS

and

a

LABA

the

same

active

ingredients

as

Advair

The

authorized

generic

is

known

as

fluticasone

propionate

and

salmeterol

inhalation

powder

multidose

dry

powder

inhaler

Teva

is

launching

both

products

at

the

same

time

in

an

effort

to

address

the

need

for

more

affordable

asthma

treatment

options

in

the

US

Teva

expects

that

sales

of

the

authorized

generic

will

represent

most

of

the

sales

of

the

two

products

With

the

launch

of

AirDuo

RespiClick

and

its

authorized

generic

our

intent

is

to

meet

the

needs

of

patients

providers

and

payers

in

the

US

seeking

greater

access

to

lowercost

asthma

inhaler

technology

while

also

allowing

Teva

to

compete

in

the

highly

competitive

asthma

combination

controller

market

said

Rob

Koremans

MD

President

and

CEO

of

Global

Specialty

Medicines

at

Teva

This

important

launch

marks

not

only

the

first

available

generic

ICSLABA

product

in

the

US

but

also

the

continued

expansion

of

our

RespiClick

family

of

products

which

now

includes

breathactivated

inhaler

options

for

both

maintenance

treatment

and

rescue

medication

AirDuo

RespiClick

was

approved

by

the

US

Food

and

Drug

Administration

FDA

in

January

in

three

doses

mcg

mcg

and

mcg

administered

as

one

inhalation

twice

daily

AirDuo

RespiClick

contains

medication

delivered

via

Tevas

RespiClick

breathactivated

multidose

dry

powder

inhaler

MDPI

which

is

used

with

other

approved

medicines

in

Tevas

respiratory

product

portfolio

About

AirDuo

RespiClick

Fluticasone

Propionate

and

Salmeterol

Inhalation

Powder

and

authorized

generic

fluticasone

propionate

and

salmeterol

inhalation

powder

multidose

dry

powder

inhaler

The

following

Indication

and

Important

Safety

Information

are

applicable

to

both

AirDuo

RespiClick

and

its

authorized

generic

AirDuo

RespiClick

is

indicated

for

the

treatment

of

asthma

in

patients

aged

years

and

older

AirDuo

RespiClick

is

only

for

patients

uncontrolled

on

an

ICS

or

whose

disease

severity

clearly

warrants

an

ICSLABA

Important

Limitation

of

Use

AirDuo

RespiClick

is

NOT

indicated

for

the

relief

of

acute

bronchospasm

IMPORTANT

SAFETY

INFORMATION

WARNING

ASTHMARELATED

DEATH

Longacting

beta

adrenergic

agonists

LABA

such

as

salmeterol

one

of

the

active

ingredients

in

AirDuo

RespiClick

increase

the

risk

of

asthmarelated

death

Data

from

a

large

placebocontrolled

US

trial

that

compared

the

safety

of

salmeterol

with

placebo

added

to

usual

asthma

therapy

showed

an

increase

in

asthmarelated

deaths

in

subjects

receiving

salmeterol

deaths

out

of

subjects

treated

for

weeks

on

salmeterol

versus

deaths

out

of

subjects

on

placebo

Currently

available

data

are

inadequate

to

determine

whether

concurrent

use

of

inhaled

corticosteroids

or

other

longterm

asthma

control

drugs

mitigates

the

increased

risk

of

asthmarelated

death

from

LABA

Available

data

from

controlled

clinical

trials

suggest

that

LABA

increase

the

risk

of

asthmarelated

hospitalization

in

pediatric

and

adolescent

patients

Therefore

when

treating

patients

with

asthma

physicians

should

only

prescribe

AirDuo

RespiClick

for

patients

not

adequately

controlled

on

a

longterm

asthma

control

medication

such

as

an

inhaled

corticosteroid

or

whose

disease

severity

clearly

warrants

initiation

of

treatment

with

both

an

inhaled

corticosteroid

and

a

LABA

Once

asthma

control

is

achieved

and

maintained

assess

the

patient

at

regular

intervals

and

step

down

therapy

eg

discontinue

AirDuo

RespiClick

if

possible

without

loss

of

asthma

control

and

maintain

the

patient

on

a

longterm

asthma

control

medication

such

as

an

inhaled

corticosteroid

Do

not

use

AirDuo

RespiClick

for

patients

whose

asthma

is

adequately

controlled

Contraindications

AirDuo

RespiClick

is

contraindicated

in

Primary

treatment

of

status

asthmaticus

or

other

acute

episodes

of

asthma

where

intensive

measures

are

required

Patients

with

known

severe

hypersensitivity

to

milk

proteins

or

known

hypersensitivity

to

fluticasone

propionate

or

any

of

the

excipients

Deterioration

of

Disease

and

Acute

Episodes

Serious

acute

respiratory

events

including

fatalities

have

been

reported

when

salmeterol

a

component

of

AirDuo

RespiClick

has

been

initiated

in

patients

with

significantly

worsening

or

acutely

deteriorating

asthma

AirDuo

RespiClick

should

not

be

initiated

in

patients

during

rapidly

deteriorating

or

potentially

lifethreatening

episodes

of

asthma

AirDuo

RespiClick

is

not

indicated

for

the

relief

of

acute

bronchospasm

An

inhaled

shortacting

beta

agonist

not

AirDuo

RespiClick

should

be

used

to

relieve

acute

symptoms

such

as

shortness

of

breath

Excessive

Use

and

Use

with

Other

Long

acting

Beta

Agonists

AirDuo

RespiClick

should

not

be

used

more

often

than

recommended

at

higher

doses

than

recommended

or

in

conjunction

with

other

medicines

containing

LABA

as

an

overdose

may

result

Clinically

significant

cardiovascular

effects

and

fatalities

have

been

reported

in

association

with

excessive

use

of

inhaled

sympathomimetic

drugs

Patients

using

AirDuo

RespiClick

should

not

use

another

medicine

containing

a

LABA

eg

salmeterol

formoterol

fumarate

arformoterol

tartrate

indacaterol

for

any

reason

Local

Effects

of

Inhaled

Corticosteroids

Oropharyngeal

candidiasis

has

occurred

in

patients

treated

with

AirDuo

RespiClick

Advise

patients

to

rinse

the

mouth

with

water

without

swallowing

following

inhalation

Immunosuppression

Patients

who

use

corticosteroids

are

at

risk

for

potential

worsening

of

existing

tuberculosis

fungal

bacterial

viral

or

parasitic

infections

or

ocular

herpes

simplex

A

more

serious

or

even

fatal

course

of

chickenpox

or

measles

may

occur

in

susceptible

patients

Use

with

caution

if

at

all

in

patients

with

the

above

because

of

the

potential

for

worsening

of

these

infections

Transferring

Patients

from

Systemic

Corticosteroid

Therapy

Particular

care

is

needed

for

patients

who

have

been

transferred

from

systemically

active

corticosteroids

to

inhaled

corticosteroids

because

deaths

due

to

adrenal

insufficiency

have

occurred

in

patients

with

asthma

during

and

after

transfer

from

systemic

corticosteroids

to

less

systemically

available

inhaled

corticosteroids

Taper

patients

slowly

from

systemic

corticosteroids

if

transferring

to

AirDuo

RespiClick

Hypercorticism

and

Adrenal

Suppression

Because

of

the

possibility

of

significant

systemic

absorption

of

inhaled

corticosteroids

patients

treated

with

AirDuo

RespiClick

should

be

observed

carefully

for

any

evidence

of

systemic

corticosteroid

effects

If

such

effects

occur

the

dosage

of

AirDuo

RespiClick

should

be

reduced

slowly

consistent

with

accepted

procedures

for

reducing

systemic

corticosteroids

and

for

management

of

asthma

symptoms

Drug

Interactions

with

Strong

Cytochrome

Inhibitors

The

use

of

strong

cytochrome

inhibitors

eg

ritonavir

atazanavir

clarithromycin

indinavir

itraconazole

nefazodone

nelfinavir

saquinavir

ketoconazole

telithromycin

with

AirDuo

RespiClick

is

not

recommended

because

increased

systemic

corticosteroid

and

increased

cardiovascular

adverse

effects

may

occur

Paradoxical

Bronchospasm

and

Upper

Airway

Symptoms

AirDuo

RespiClick

can

produce

paradoxical

bronchospasm

which

may

be

lifethreatening

If

paradoxical

bronchospasm

occurs

following

dosing

with

inhaled

fluticasone

propionatesalmeterol

medicines

it

should

be

treated

immediately

with

an

inhaled

shortacting

bronchodilator

inhaled

fluticasone

propionatesalmeterol

medicines

should

be

discontinued

immediately

and

alternative

therapy

should

be

instituted

Upper

airway

symptoms

of

laryngeal

spasm

irritation

or

swelling

such

as

stridor

and

choking

have

been

reported

Hypersensitivity

Reactions

Including

Anaphylaxis

Immediate

hypersensitivity

reactions

eg

urticaria

angioedema

rash

bronchospasm

hypotension

including

anaphylaxis

may

occur

after

administration

of

AirDuo

RespiClick

Discontinue

AirDuo

RespiClick

if

such

reactions

occur

Cardiovascular

and

Central

Nervous

System

Effects

AirDuo

RespiClick

should

be

used

with

caution

in

patients

with

cardiovascular

disorders

especially

coronary

insufficiency

cardiac

arrhythmias

and

hypertension

Salmeterol

a

component

of

AirDuo

RespiClick

can

produce

clinically

significant

cardiovascular

effects

in

some

patients

as

measured

by

pulse

rate

blood

pressure

andor

symptoms

If

such

effects

occur

AirDuo

RespiClick

may

need

to

be

discontinued

Reduction

in

Bone

Mineral

Density

BMD

Decreases

in

BMD

have

been

observed

with

longterm

administration

of

products

containing

inhaled

corticosteroids

Patients

with

major

risk

factors

for

decreased

bone

mineral

content

such

as

prolonged

immobilization

family

history

of

osteoporosis

or

chronic

use

of

drugs

that

can

reduce

bone

mass

eg

anticonvulsants

oral

corticosteroids

should

be

monitored

and

treated

with

established

standards

of

care

Effect

on

Growth

Inhaled

corticosteroids

including

AirDuo

RespiClick

may

cause

a

reduction

in

growth

velocity

when

administered

to

pediatric

patients

Monitor

the

growth

of

pediatric

patients

receiving

AirDuo

RespiClick

routinely

eg

via

stadiometry

Titrate

each

patients

dosage

to

the

lowest

dosage

that

effectively

controls

hisher

symptoms

Glaucoma

and

Cataracts

Glaucoma

increased

intraocular

pressure

and

cataracts

have

been

reported

in

patients

with

asthma

following

the

longterm

administration

of

inhaled

corticosteroids

including

fluticasone

propionate

Therefore

close

monitoring

is

warranted

in

patients

with

a

change

in

vision

or

with

a

history

of

increased

intraocular

pressure

glaucoma

andor

cataracts

Eosinophilic

Conditions

and

ChurgStrauss

Syndrome

Systemic

eosinophilic

conditions

such

as

ChurgStrauss

syndrome

may

occur

These

events

usually

but

not

always

have

been

associated

with

the

reduction

andor

withdrawal

of

oral

corticosteroid

therapy

following

the

introduction

of

fluticasone

propionate

Be

alert

to

eosinophilia

vasculitic

rash

worsening

pulmonary

symptoms

cardiac

complications

andor

neuropathy

Coexisting

Conditions

Use

with

caution

in

patients

with

convulsive

disorders

thyrotoxicosis

diabetes

mellitus

ketoacidosis

and

in

patients

who

are

unusually

responsive

to

sympathomimetic

amines

Hypokalemia

and

Hyperglycemia

Be

alert

to

hypokalemia

and

hyperglycemia

Adverse

Reactions

Most

common

adverse

reactions

in

patients

taking

AirDuo

RespiClick

mcg

twice

daily

mcg

twice

daily

mcg

twice

daily

and

placebo

respectively

were

nasopharyngitis

oral

candidiasis

back

pain

headache

and

cough

Drug

Interactions

Inhibitors

of

Cytochrome

The

use

of

strong

inhibitors

eg

ritonavir

atazanavir

clarithromycin

indinavir

itraconazole

nefazodone

nelfinavir

saquinavir

ketoconazole

telithromycin

with

AirDuo

RespiClick

is

not

recommended

because

increased

systemic

corticosteroid

and

increased

cardiovascular

adverse

effects

may

occur

Monoamine

Oxidase

Inhibitors

and

Tricyclic

Antidepressants

AirDuo

RespiClick

should

be

administered

with

extreme

caution

to

patients

being

treated

with

monoamine

oxidase

inhibitors

or

tricyclic

antidepressants

or

within

weeks

of

discontinuation

of

such

agents

because

the

action

of

salmeterol

a

component

of

AirDuo

RespiClick

on

the

vascular

system

may

be

potentiated

by

these

agents

BetaAdrenergic

Receptor

Blocking

Agents

Betablockers

not

only

block

the

pulmonary

effect

of

betaagonists

such

as

salmeterol

a

component

of

AirDuo

RespiClick

but

may

also

produce

severe

bronchospasm

in

patients

with

asthma

Therefore

patients

with

asthma

should

not

normally

be

treated

with

betablockers

NonPotassiumSparing

Diuretics

The

ECG

changes

andor

hypokalemia

that

may

result

from

the

administration

of

nonpotassiumsparing

diuretics

such

as

loop

or

thiazide

diuretics

can

be

acutely

worsened

by

betaagonists

such

as

salmeterol

a

component

of

AirDuo

RespiClick

Caution

is

advised

in

the

coadministration

of

AirDuo

RespiClick

with

nonpotassiumsparing

diuretics

Use

in

Specific

Populations

Since

both

fluticasone

propionate

and

salmeterol

are

predominantly

cleared

by

hepatic

metabolism

impairment

of

liver

function

may

lead

to

accumulation

of

fluticasone

propionate

and

salmeterol

in

plasma

Therefore

patients

with

hepatic

disease

should

be

closely

monitored

Please

click

here

for

full

Prescribing

Information

including

Boxed

WARNING

httpairduorespiclickcomassetspdfPIpdf

httpswwwtevagenericscomassetsbaseLaunchMaterialsFluticasoneFluticasonePropionateSalmeterolInhalationPowder_PIpdf

About

Asthma

Asthma

is

a

chronic

long

term

disease

usually

characterized

by

airway

inflammation

and

narrowing

of

the

airways

which

can

vary

over

time

Asthma

may

cause

recurring

periods

of

wheezing

a

whistling

sound

when

you

breathe

chest

tightness

shortness

of

breath

and

coughing

that

often

occurs

at

night

or

early

in

the

morning

Without

appropriate

treatment

asthma

symptoms

may

become

more

severe

and

result

in

an

asthma

attack

which

can

lead

to

hospitalization

and

even

death

About

Teva

Respiratory

Teva

Respiratory

develops

and

delivers

highquality

treatment

options

for

respiratory

conditions

including

asthma

COPD

and

allergic

rhinitis

The

Teva

Respiratory

portfolio

is

centered

on

optimizing

respiratory

treatment

for

patients

and

healthcare

providers

through

the

development

of

novel

delivery

systems

and

therapies

that

help

address

unmet

needs

The

companys

respiratory

pipeline

and

clinical

trial

program

are

based

on

drug

molecules

delivered

in

proprietary

dry

powder

formulations

and

breathactivated

device

technologies

as

well

as

a

targeted

biologic

treatment

for

severe

asthma

Through

research

and

clinical

development

Teva

Respiratory

continually

works

to

expand

strengthen

and

build

upon

its

treatment

portfolio

to

positively

impact

About

Teva

Teva

Pharmaceutical

Industries

Ltd

NYSE

and

TASE

TEVA

is

a

leading

global

pharmaceutical

company

that

delivers

highquality

patientcentric

healthcare

solutions

used

by

approximately

million

patients

in

markets

every

day

Headquartered

in

Israel

Teva

is

the

worlds

largest

generic

medicines

producer

leveraging

its

portfolio

of

more

than

molecules

to

produce

a

wide

range

of

generic

products

in

nearly

every

therapeutic

area

In

specialty

medicines

Teva

has

the

worldleading

innovative

treatment

for

multiple

sclerosis

as

well

as

latestage

development

programs

for

other

disorders

of

the

central

nervous

system

including

movement

disorders

migraine

pain

and

neurodegenerative

conditions

as

well

as

a

broad

portfolio

of

respiratory

products

Teva

is

leveraging

its

generics

and

specialty

capabilities

in

order

to

seek

new

ways

of

addressing

unmet

patient

needs

by

combining

drug

development

with

devices

services

and

technologies

billion

For

more

information

visit

wwwtevapharmcom

Cautionary

Note

Regarding

ForwardLooking

Statements

This

press

release

contains

forwardlooking

statements

within

the

meaning

of

the

Private

Securities

Litigation

Reform

Act

of

regarding

the

launch

of

AirDuo

RespiClick

and

its

Authorized

Generic

which

are

based

on

managements

current

beliefs

and

expectations

and

are

subject

to

substantial

risks

and

uncertainties

both

known

and

unknown

that

could

cause

our

future

results

performance

or

achievements

to

differ

significantly

from

that

expressed

or

implied

by

such

forwardlooking

statements

Important

factors

that

could

cause

or

contribute

to

such

differences

include

risks

relating

to

the

uncertainty

of

the

commercial

success

of

AirDuo

RespiClick

and

its

Authorized

Generic

our

generics

medicines

business

including

that

we

are

substantially

more

dependent

on

this

business

with

its

significant

attendant

risks

following

our

acquisition

of

Allergan

plcs

worldwide

generic

pharmaceuticals

business

Actavis

Generics

our

ability

to

realize

the

anticipated

benefits

of

the

acquisition

and

any

delay

in

realizing

those

benefits

or

difficulties

in

integrating

Actavis

Generics

the

increase

in

the

number

of

competitors

targeting

generic

opportunities

and

seeking

US

market

exclusivity

for

generic

versions

of

significant

products

price

erosion

relating

to

our

generic

products

both

from

competing

products

and

as

a

result

of

increased

governmental

pricing

pressures

and

our

ability

to

take

advantage

of

highvalue

biosimilar

opportunities

our

specialty

medicines

business

including

competition

for

our

specialty

products

especially

Copaxone

our

leading

medicine

which

faces

competition

from

existing

and

potential

additional

generic

versions

and

orallyadministered

alternatives

our

ability

to

achieve

expected

results

from

investments

in

our

product

pipeline

competition

from

companies

with

greater

resources

and

capabilities

and

the

effectiveness

of

our

patents

and

other

measures

to

protect

our

intellectual

property

rights

our

business

and

operations

in

general

including

our

ability

to

develop

and

commercialize

additional

pharmaceutical

products

manufacturing

or

quality

control

problems

which

may

damage

our

reputation

for

quality

production

and

require

costly

remediation

interruptions

in

our

supply

chain

disruptions

of

our

or

third

party

information

technology

systems

or

breaches

of

our

data

security

the

restructuring

of

our

manufacturing

network

including

potential

related

labor

unrest

the

impact

of

continuing

consolidation

of

our

distributors

and

customers

and

variations

in

patent

laws

that

may

adversely

affect

our

ability

to

manufacture

our

products

compliance

regulatory

and

litigation

matters

including

costs

and

delays

resulting

from

the

extensive

governmental

regulation

to

which

we

are

subject

the

effects

of

reforms

in

healthcare

regulation

and

reductions

in

pharmaceutical

pricing

reimbursement

and

coverage

potential

additional

adverse

consequences

following

our

resolution

with

the

US

government

of

our

FCPA

investigation

governmental

investigations

into

sales

and

marketing

practices

potential

liability

for

sales

of

generic

products

prior

to

a

final

resolution

of

outstanding

patent

litigation

product

liability

claims

increased

government

scrutiny

of

our

patent

settlement

agreements

failure

to

comply

with

complex

Medicare

and

Medicaid

reporting

and

payment

obligations

and

environmental

risks

and

wwwsecgov

and

wwwtevapharmcom

Forwardlooking

statements

speak

only

as

of

the

date

on

which

they

are

made

and

we

assume

no

obligation

to

update

or

revise

any

forwardlooking

statements

or

other

information

contained

herein

whether

as

a

result

of

new

information

future

events

or

otherwise

You

are

cautioned

not

to

put

undue

reliance

on

these

forwardlooking

statements

View

source

version

on

businesswirecom

Source

Teva

Pharmaceutical

Industries

Ltd

Teva

Pharmaceutical

Industries

Ltd

IR

Contacts

United

States

Kevin

C

Mannix

or

Ran

Meir

or

Israel

Tomer

Amitai

or

PR

Contacts

Israel

Iris

Beck

Codner

or

United

States

Denise

Bradley

or

Nancy

Leone

O O O O O O B I O B O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B I O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B I O O O O O O O O O O O O O O O O O O B I O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B I O O O O O O O O O O O O O O O O O O B I O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B I O O O O O O O O O O O O O O O O O O O O O O O O O B I O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B I O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B I O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O


Intensive Outpatient Programs Home Behavioral Health Services Offered Intensive Outpatient Programs Services Offered Inpatient Adult Psychiatric Services Inpatient Adolescent Psychiatric Services Inpatient Adult Detoxification Partial Hospital Programs Intensive Outpatient Programs Residential Addiction Treatment The Texas Health Behavioral Health Intensive Outpatient Programs are for individuals needing a structured therapy program that offers counseling and education in a group setting Clinicians work with physicians on the medical staff to provide daily support and a safe place to talk learn problemsolving skills and practice stressreduction techniques These programs include Adult Psychiatric Care Adult Addiction Treatment Adolescent Psychiatric Care Eating Disorders Texas Health Behavioral Health also offers the following Specialized Intensive Outpatient Programs Women The Texas Health Behavioral Health Program for Women is an outpatient program that addresses the treatment of depression in women including postpartum depression loss of a child including miscarriage and hormonerelated depression The Womens Outpatient Program addresses the physical emotional spiritual and interpersonal needs of adult women who face emotional difficulties and stressful life situations Young Adult The young adult program addresses the agespecific issues of young adults ages 1825 The program is geared toward the behavioral health challenges that the young adult faces including selfidentity graduation independence college pressures change in family dynamics introduction to work force peer pressures healthy relationships and alcohol or drug issues The program encourages family participation and offers a weekly psychoeducation component to include the whole family in the young adults healthier lifestyle and overall transformation Working Professionals Texas Health Behavioral Health offers a program designed for the professional coping with workrelated issues including stress anxiety workplace changes burnout conflict with coworkers effective coping skills and returntowork anxiety A significant benefit to the Working Professionals program is the ability for the professional to receive treatment while continuing to meet the obligations of work home and family The Texas Health Behavioral Health program also works with professionals who require treatment to keep their license or certificate or who are currently on leave of absence The program targets overall stabilization promotes achievement of realistic goals and helps transition professionals expeditiously back into a healthier workforce Texas Health Behavioral Health employees are trained in assisting with FMLA and disability paperwork among HR EAP and authorized personnel Lets talk Sometimes patients take the first step themselves Other times its a family member or health professional who is concerned about that persons wellbeing A complimentary assessment is the first step in creating a personalized care plan Contact us today The Texas Health Behavioral Health help line is open 24 hours a day seven days a week 6822366023 For more information or to schedule your complimentary assessment

B I I O O O O O B I I O O O O O O O O O O O O O O O O B I I O O O O B I O O B I I O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B I O O O O O O O B I I O O B I O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B I O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B I O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B I O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B I O O O O O O O O O O O O O O O O O O O O O O O O

intensive outpatient programs
texas health


How Texas Colleges Have Responded to the Hate Groups Behind All Those Racist Flyers Records show a few dozen angry young white men led by a teenager from the Dallas suburbs and emboldened by Trump have caused headaches at universities across the state by Candice Bernd and Jordan Buckley January 29 2018 Flyers found on Texas college campuses since the 2016 election Police records obtained by the Observer T he first flyers appeared on November 9 2016 plastered on lampposts and in bathroom stalls across Texas State University Now that our man TRUMP is elected and republicans own both the senate and the house time to organize tar feather VIGILANTE SQUADS and go arrest torture those deviant university leaders spouting off all this Diversity Garbage read one It happened again and again not just at Texas State but also at the University of North Texas Rice University the University of Texas at Dallas and others Look around white man Is this the country your ancestors died for Imagine a Muslimfree America A Notice To All White Americans It Is Your Civic Duty To Report Any and All Illegal Aliens Many of the flyers bore the logo and website of American Vanguard a group whose manifesto begins White America is under attack or later those of a splinter group called Patriot Front More than a year after the 2016 election hateful messages paired with fascist and Nazi symbols continue popping up on college campuses across Texas and administrators are still struggling with how to respond Records obtained by the Observer show how colleges attempt to balance campus safety police resources and freespeech protections as they react to guerilla propaganda campaigns Taken together the hodgepodge of responses illustrate the outsized disturbance that a group of a few dozen angry young white men led by a 19yearold from the Dallas suburbs have caused for Texas colleges Thomas Rousseau left and James Fields far right don American Vanguard uniforms at the Unite the Right rally in Charlottesville ItsGoingDownorg Patriot Front a neoNazi group led by Coppell native Thomas Rousseau came out of a splintering of white supremacist and altright groups in the aftermath of the Unite the Right rally in Charlottesville Rousseau a thenlieutenant of American Vanguard wore the hate groups uniform at the rally as he stood alongside James Fields the murder suspect who allegedly rammed a vehicle into a crowd there killing one and injuring 19 Tyler Tenbrink Colton Fears and William Fears Alachua County Jail Two months later three Texas men linked to Patriot Front were charged with attempted homicide after an altercation outside a speech by white supremacist leader Richard Spencer at the University of Florida in Gainesville William and Colton Fears brothers from Pasadena Texas as well as Tyler Tenbrink of Richmond Texas allegedly yelled Heil Hitler at a group of counterprotesters and Tenbrink fired a gun police said Rousseau was on the FBIs radar as early as May 2017 records show when he was still attending Coppell High School In emails to North Texas campus police departments obtained by the Observer a special agent and a domestic terrorism investigator identified Rousseau and three other white men as having posted propaganda posters with language used by white supremacy extremist groups on Dallas campuses In September Rousseau and other patriots carried a giant banner For Race And Nation Blood and Soil to a book fair in Houston and confronted attendees with homophobic and racist language They were kicked off the University of Texas at Austin campus in November after Rousseau led a torchwielding publicity stunt in front of the schools iconic tower In December the group passed out flyers to tourists on San Antonios River Walk and waved American and Texas flags in front of the Alamo as Rousseau ranted on a bullhorn CourtesyYouTube Carla Hill senior researcher for the AntiDefamation League ADL said her organization has tracked 59 instances in Texas of racist propaganda the majority associated with Patriot Front and American Vanguard in Austin Dallas Houston San Antonio San Marcos Tyler Wichita Falls and other cities since Trump was elected She said more incidents have been reported at Texas State than any other campus in the state Hill said that Patriot Front has about 70 active members nationwide and a few small clusters scattered across Texas are responsible for most of the flyers Most Patriot Front members not including Rousseau wear masks when demonstrating or posting neoNazi flyers and use pseudonyms online When contacted by an Observer reporter seeking comment Rousseau hung up as soon as she identified herself In one of the few instances in which people posting the neoNazi flyers were caught redhanded Texas State police with the help of student witnesses detained five white nonstudent men who admitted on December 3 to posting about 3040 flyers and two banners on campus as well as several other posters at a San Marcos apartment complex according to a police report A racist flyer found on the Texas State University campus Carolina Martínez Some of the flyers which included the Patriot Front website targeted Texas State student Rudy Martinez the author of a controversial column about race in the student newspaper The posters included Martinezs face name phone number and employers contact information a tactic known as doxxing and encouraged people to contact him and his employer Police detained questioned and released the men with a criminal trespass warning University spokesperson Matt Flores said he doesnt know if officers were aware the posters referenced a Texas State student but that the police department typically issues criminal trespass warnings to individuals who are caught for the first time violating university policies Texas State has refused to name the men citing a school policy to not identify individuals cited with a warning T he university redacted the mens names from a release of public information to the Observer and is seeking a ruling from the attorney general to keep them private The Observer has challenged the appeal Tafari Robertson a public relations senior and activist at Texas State likened the refusal to identify or charge the men to protecting the hate groups Rebecca BellMetereau a Texas State English professor echoed that sentiment It seems that for the safety and security of students on the Texas State campus we deserve to know the names of individuals who are posting intimidating hate speech on our campus she told the Observer At the University of North Texas UNT officers struggled with how to balance campus safety and freespeech protections Weve now been out to Wooten Hall three times in two days for the same groups posters being put up on bulletin boards UNT Patrol Supervisor Lieutenant Jeremy Polk wrote in a January 2017 email obtained by the Observer Polk instructed officers not to respond to similar reports unless there is something threatening and that public boards are free speech protected Other schools in Dallas seemed to take a more proactive approach The University of Texas at Dallas UTD deployed an officer to investigate members of the hate groups that were seen posting what police internally called white supremacists flyers on campus in surveillance footage In an internal email the investigator identified Brett Sanders an American Vanguard member from Frisco as one of the men in the surveillance footage noting that the header on his Facebook profile page is SMASH CULTURAL MARXISM and his profile photo is of himself in a red Trump hat and he is kissing some type of automatic weapon UTD police then circulated a memo alerting officers in the area to be on the lookout for Sanders while noting that it wasnt immediately clear if he had committed a crime Similarly Southern Methodist University publicly released surveillance video of five men who hung a white supremacist banner on campus inviting the Dallas community to help identify the perpetrators That investigation remains open In October Lieutenant Governor Dan Patrick ordered senators during the interim to ascertain any restrictions on Freedom of Speech rights that Texas students face in expressing their views on campus and recommend policy changes that protect First Amendment rights and enhance the free speech environment on campus Responding to Patricks call the Senate Committee on State Affairs is set to hold a hearing on free speech at Texas State The agenda for the Wednesday meeting notes in bolded letters that Public testimony will be limited to 2 minutes Get the latest Texas Observer news analysis and investigations via and our weekly newsletter Enter your email Read More AltRight Donald Trump hate incidents Nazis racism Texas State University The University of Texas at Austin University of North Texas Top

O B O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B I O O O O O O O O O B O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B O O O O O O O O B O O O O O B O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B O O O O O O O B O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B O O O O O O O O O O O O O B I O O O O O O O O O O O O O O O B O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B O O O O O O O O O O O O O O O O O O O O O O O O O O B O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B O O O O O O O O O O O O O O O O B O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B O O O O O O O O O O O O O O O O O O O O O O O O B O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B O O O O O O O O O O O O O O O O O O B O O O O O O O O O O O O O O O O O O B O O O O O O O O O O O O O O O O O O O O O O O O O O O O B O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B O O O O O O O O O O O O O O O O O O O O O O O B O O O O O O O O O O O O O O O O O O O O O O B O O O O O B O O O O O B O


The future of bus services Buses are vital to the cityregions economy and society At least three in every four public transport journeys in Greater Manchester are made by bus And yet there has been a steady decline in the number of people travelling by bus There are now around 140 million fewer bus journeys each year than thirty years ago Thats despite significant public funding and commercial investment by bus operators Greater Manchester is growing with the population set to exceed 3 million by 2040 By 2035 our transport network will need to support an additional 600000 journeys a day Its vital that the bus network plays a fuller role in connecting people with jobs housing education healthcare shops family and friends The current system More than 40 bus operators run services in Greater Manchester Because its a deregulated market no single organisation is responsible for planning the bus network or setting fares As a result the current system prevents bus services being fully joined up and coordinated with each other as well as different types of transport The number and variety of bus tickets in Greater Manchester is complicated Passengers have to pay more for a ticket that they can use on more than one bus operators network Travelling by bus needs to be easier Bus reform The Greater Manchester 2040 Transport Strategy sets out our ambition for bus services Greater Manchester needs a joinedup transport network with simple fares and ticketing that puts the passenger first and guarantees the best value ticket for their journey It should be modern accessible and everyone should be able to use it This can only be fully achieved through a change to the current bus system In April 2017 the Bus Services Act became law giving Mayoral authorities like Greater Manchester powers to improve bus services by reforming the current bus market The options available include franchising the system used in London and other cities globally and partnerships Andy Burnham Greater Manchester Mayor made a commitment in his manifesto to use these new powers to make local bus services more affordable more reliable and more accessible What next On behalf of Greater Manchester Combined Authority GMCA and in line with the Bus Services Act TfGM is now preparing an assessment of a proposed franchising scheme for the whole of Greater Manchester As part of this assessment we are also engaging with bus operators This is allowing us to consider and assess other realistic options to improve bus services such as partnership proposals Once the assessment is complete it will be independently audited in line with the Bus Services Act 2017 The Combined Authority would then consider the assessment and the auditors report and make a decision on whether to continue with the proposed scheme If so the Authority would then hold a consultation to allow the public to have their say on the proposed franchising scheme GMCA would then publish a report on its responses to the consultation and the Mayor would make a decision about whether to use the powers made available to him under the Bus Services Act 2017 to reform Greater Manchesters bus market by implementing the proposed scheme or not Please check back for updates

B I I I I O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B I O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O


Industry Regulation basics Safety information for industry Medicines safety monitoring Pharmacovigilance Inspection Program Pharmacovigilance responsibilities of medicine sponsors Australian recommendations and requirements 27 June 2018 Introduction Pharmacovigilance is defined by the World Health Organization as the science and activity related to detecting assessing understanding and preventing adverse effects and other medicinerelated problems The Therapeutic Goods Administration TGA collects and evaluates information related to the benefitrisk balance of medicines in Australia to monitor their safety and where necessary take appropriate action This guidance sets out the pharmacovigilance responsibilities of sponsors of medicines included on the Australian Register of Therapeutic Goods ARTG and regulated by the TGA It outlines the mandatory reporting requirements and offers recommendations on pharmacovigilance best practice In this guidance we use must or required to describe something you are legally obliged to do We use should to recommend an action that will assist you to meet your legal requirements We refer to the TGA as we or us and to sponsors as you In this section Scope Responsibilities Adverse events and adverse reactions Significant safety issues Scope This guidance applies to all sponsors who have medicines registered or listed on the Australian Register of Therapeutic Goods ARTG describes your reporting and recordkeeping requirements offers recommendations on the monitoring collection and management of safety data to help you achieve best practice pharmacovigilance outlines the legal basis for pharmacovigilance requirements associated with medicines on the ARTG This guidance is mostly consistent with the European Medicines Agencys EMA Guideline on Good Pharmacovigilance Practices GVP Module VI Management and reporting of adverse reactions to medicines Some requirements and recommendations however are specific to Australia Responsibilities You MUST meet your pharmacovigilance reporting responsibilities for all the medicines you have registered or listed on the Australian Register of Therapeutic Goods ARTG This is regardless of their Australian marketing status that is whether they are currently available for purchase withdrawn from sale or otherwise supplied eg in a companysponsored postregistration study Unapproved medicines used in Clinical trials or supplied under the Special Access Scheme SAS or Authorised Prescriber are subject to separate reporting requirements and are not covered by these guidelines You as a sponsor of medicines approved for supply in Australia are legally responsible for meeting pharmacovigilance reporting requirements for your medicine You MUST let us know who your Australian pharmacovigilance contact person is submit any serious adverse reaction reports to us notify us of any significant safety issues you identify keep records pertaining to the reporting requirements and safety for your medicine under Subsection 285ca of the Therapeutic Goods Act 1989 the Act answer any request from us for additional information fully and within the specified timeframe under Subsection 311 of the Act This includes situations where separate sponsors market two or more separately registered or listed medicines that are considered identical in all respects apart from their trade names sponsors share or outsource marketing or distribution arrangements pharmacovigilance activities are contracted to external organisations We expect you to have an effective pharmacovigilance system in place in order to monitor and take responsibility for the safety of your medicine meet legislative requirements for reporting serious adverse reactions and significant safety issues identify any changes to the benefitrisk balance of your medicine take appropriate action in a timely manner when necessary update product labels and product information PI with new safety information in a timely way Adverse events and adverse reactions Pharmacovigilance distinguishes between adverse events and adverse reactions Adverse events An adverse event is any untoward medical occurrence in a patient consumer or clinical investigation subject administered a medicine which does not necessarily have a causal relationship with this treatment An adverse event can therefore be any unfavourable and unintended sign for example an abnormal laboratory finding symptom or disease temporally associated with the use of a medicine whether or not it is considered related to the medicine Adverse reactions An adverse reaction is a noxious and unintended response to a medicine The phrase response to a medicine means there is at least a reasonable possibility that the medicine caused the adverse event A reaction in contrast to an event is characterised by the fact that a sponsor investigator or reporter suspects there is a causal relationship between the medicine and the occurrence This guidance describes the reporting requirements that apply to adverse reactions as opposed to adverse events identified from all sources including adverse reactions that arise from the use of a medicine within the terms of approved indications as per the product information or ARTG the use of a medicine outside the terms of the approved indications including overdose abuse misuse offlabel use and medication errors occupational exposure Note synonyms of adverse reactions include adverse drug reaction ADR suspected adverse drug reaction adverse effect and undesirable effect For regulatory reporting purposes if an adverse event is spontaneously reported even if the causal relationship is unknown or unstated it meets the definition of an adverse reaction Therefore all spontaneous reports notified by healthcare professionals or consumers are considered suspected adverse reactions since they convey the suspicions of the primary sources unless the reporter specifically state they believe the events to be unrelated or that a causal relationship can be excluded You should make reasonable attempts to obtain additional information so you can assess causality Expected and unexpected adverse reactions An expected adverse reaction is an adverse reaction known to be associated with the use of the medicine as reflected in the product information document or label warning statement An unexpected adverse reaction is an adverse reaction in which its nature that is its specificity or outcome severity or frequency is either not identified or not consistent with the term or description used in the product information document or label warning statement Regulatory reporting requirements apply to both expected and unexpected adverse reactions Serious adverse reactions A serious adverse reaction is any medical occurrence that in relation to a medicine at any dose results in death is lifethreatening results in inpatient hospitalisation or prolonged hospitalisation results in persistent or significant disability or incapacity is associated with a congenital anomaly or birth defect see Reports in pregnancy and breastfeeding is a medically important event or reaction Nonserious adverse reactions Nonserious adverse reactions are adverse reactions that do not meet the definition of a serious adverse reaction Significant safety issues A significant safety issue is a new safety issue or validated signal considered by you in relation to your medicines that requires urgent attention of the TGA This may be because of the seriousness and potential major impact on the benefitrisk balance of the medicine andor on patient or public health which could warrant prompt regulatory action andor communication to patients and healthcare professionals You can identify significant safety issues as a result of ongoing review and analysis of all information that is pertinent to the safety or benefitrisk balance of the medicine Examples of significant safety issues include safetyrelated actions by comparable international regulatory agencies such as the withdrawal or suspension of the medicines availability the addition or modification for safety reasons of a contraindication warning or precaution statement to the product information or label the modification or removal for safety reasons of an indication changes in the nature severity or frequency of known serious adverse reactions which are medically significant detection of new risk factors for the development of a known adverse reaction or a new serious adverse reaction that may impact on the safety or benefitrisk balance of the medicine series of reports of similar or linked adverse reactions reported at the same time that is a cluster assessed to suggest a quality defect issue that may have implications for public health an unusual and significant lack of efficacy occurring in or outside Australia that may have implications for public health major safety findings from a newly completed nonclinical study postregistration study or clinical trial that may impact the benefitrisk balance of the medicine on the ARTG a signal of a possible teratogenic effect or of significant hazard to public health safety issues related to any raw materials used in the medicine that may impact the safety of the medicine andor have implications for public health safety issues due to misinformation in the product information or label that may impact the safety of the medicine safety issues related to use outside the approved indication or intended use that may impact the safety or benefitrisk balance of the medicine We use the information you report to take appropriate action if deemed necessary We may provide further safety information to the public request updates to product information documents and labels impose additional risk management interventions or pharmacovigilance activities or rarely remove a medicine from the market We expect you to use your professional judgement in determining whether a safety issue is significant The examples above are not intended to be an exhaustive list of significant safety issues and it is up to you to assess safety issues on a casebycase basis and evaluate whether this has an impact on the medicines safety or benefitrisk balance andor implications for public health All pertinent factors should be taken into account when assessing a safety issue Issues to consider include the medicine the risks involved and the regulatory context Further a safety issue leading to international regulatory action is considered to be significant and hence reportable regardless of whether you agree with the recommendations and conclusions of the international regulator If you determine after appropriate assessment that a safety issue is not significant and do not report it you should document a justification for this decision We may ask you to provide this documentation at any time If in doubt about a safety issue treat it as significant or contact us for advice Category Safety of medicines medical devices Tags pharmacovigilance regulatory guidance URL httpswwwtgagovaunode763772

O O O O O O O O O O B O O B O O B I O O O O O O O O B O O O O B I I O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B O O O O O B O O O O O O O O O O O O O O O O O O O O O B O O O O O O O O O O O O O O O O O O O O O O O O O O B O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B O O O O O O O O O O O O O B O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B O O O O O O O O O O O O O B O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B O O O O

pharmacovigilance
world health organization
medicine sponsors


Festive Opening Hours Thursday 27th to Sunday 30th OPEN 10am 5pm Monday 31st to Friday 4th CLOSED Beckett Street Leeds LS9 7LN Explore the incredible world of medicine Travel back to the dirty streets of Leeds to explore life among the grime and the bedbugs Take a trip to the Victorian quack doctor will the prescribed cure make you better or worse Enter the frightening world of surgery before the discovery of pain relief As you travel forwards in time explore scientific discoveries and innovations that have changed all our lives for the better Whats on Buy a LEGO brick today Visit Reviews Wonderful exhibits lovely cafe and very good gift shop Its a really good experience Barbara on Trip Advisor Fab place learnt a lot My family I love visiting this museum also has a lovely cafe very clean toilets Highly recommended Caroline on Trip Advisor Fabulous Medical Museum This is well worth a visit a great cafe and the gift shop Do go and take the kids Jazzypj on Trip Advisor The food here is excellent LillyMae Best museum outside of London Keith on Trip Advisor

O O O O O O O O O O O O O O O O O O O O O O O O O O O B O O O O O O O O O O O O O O O O O O O O O O B I I O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O


Hospitality Cushman Wakefield Thalhimer Hospitality Group provides innovative transaction solutions and support for all types of hospitality properties including luxury fullservice selectservice boutique resort and economy hotels Hotel Investment Sales Cushman Wakefield Thalhimer provides transaction services to hotel buyers and sellers including financial institutions owneroperators developers private equity firms REITs and management companies For sellers we develop a customized marketing strategy and utilize quality marketing material our proprietary databases various marketing channels and our relationships throughout the industry to market sell and maximize the exposure in turn the value of the asset For buyers we search inventories of hotels andor development sites and match our buyers needs and wants with the right opportunity We work very closely with our clients throughout the entire transaction process Research We provide our clients with knowledge of markets in which they do business by working closely with our affiliate companys leading research staff and keeping in tune with hotel industry research and trends Valuation and Advisory Cushman Wakefield Thalhimers Valuation Advisory Group through our affiliation with Cushman Wakefield is one of the largest fully integrated real estate valuation and consulting organizations in the world We act as the foremost valuation advisor to corporations institutional investors and lenders on critical debt and equity investment decisions Capital Markets The Capital Markets Group provides advice execution and investment management services to clients engaged in buying selling investing in financing or building real estate These services typically are provided to private and institutional owners and investors as well as to corporate owners and occupiers Our objective is to advise clients on how to maximize the value of their real estate We assist in extracting that value through the application of sophisticated financial strategies and funding mechanisms Our efforts include but are not limited to investment sales and purchases joint ventures saleleasebacks traditional mortgages private placements securities underwriting mezzanine financing loan syndication and other financing vehicles Other services Feasibility and valuation Development advisory Operator selection Industrial Services Office Services Retail Services Capital Markets Landlord Representation Tenant Representation Property Management Hospitality MultiFamily Advisory Group Development Project Management Contact us Contact an Office Contact an Associate Join our Mailing List

O B I B I I O O O O O O O O O O O O O O O O O O O O O O O O B I O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B I O O O O O O O O B I O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O

thalhimer hospitality group
cushman wakefield


Home All Careers Fashion Apparel Fashion Designer Fashion Designer The field of fashion design is ripe with opportunity for any artist with a passion for style and transcending convention The industry allows fashion designers to be creative and chic eagerly drawing on ideas from their unique imaginations Fashion designers create art while simultaneously maintaining visionary perspectives FIND A SCHOOL Bachelors Degree 65170 Per Year 3 Job Growth Career Information Salary Employment Jobs Helpful Resources Fashion Designer What Is a Fashion Designer Fashion designers apply design and art principals to clothing and apparel or accessories in ways that make clothing both functional and aesthetically beautiful Initially designers will start by researching consumer tastes and trends in the fashion market They will then draw and recommend or submit an initial concept for the design They either sketch the concept or they place fabric over a mannequin to get an initial sense of what the design will look like and whether or not it will work well and look good as a finished product Fashion designers rarely work alone because the process of designing a concept physically applying the pattern to the article of clothing constructing the finished product and bringing it all together can often be too much for one person to handle This is why fashion designers usually work in teams with professional patternmakers professional samplemakers and merchandisers to ensure that the design will look good and will sell well once it makes it to market Most assume that fashion designers have any easy job and that fashion design education is all about learning design techniques and studying consumer behavior but the Today the fashion design profession is growing in popularity mainly because it is thought to be so glamorous After all it can be exciting to see celebrities or everyday citizens wearing clothing or patterns that you designed But it is also a competitive arduous detailoriented and difficult industry and it takes a certain type of individual to succeed Becoming a fashion designer is not for the faint of heart and will require plenty of patience and perseverance but for those who make it the rewards can be great Fashion Designer Job Description Work Environment Working as an independent selfemployed fashion designer can require incredibly long hours persistence tenacity and a lot of patience According to the US Bureau of Labor Statistics about one in four designers were selfemployed in 2014 There are different ways a selfemployed fashion designer can earn a living too Some fashion designers will sell their work to fashion houses or clothing manufacturers while other fashion designers start their own labels Other fashion designers work specifically with a specialty or department store designing individualized or customized clothing specifically for one store buyer Branching out on your own as a fashion designer can be rather difficult It can also a bit challenging to make a living unless you are experienced or extremely talented or have built a good reputation because most of the fashion design jobs are with wholesalers or large clothing manufacturers like Gap Inc or Abercrombie Fitch These wholesalers design their clothing to either be sold in stores or to independent stores catalogs and to online businesses The designers who work with these manufacturers are usually referred to as inhouse designers who work as part of a larger team that sees Beyond being selfemployed most fashion designers work for apparel piece goods and notions merchant wholesalers in apparel manufacturing in management positions for companies and in specialized design services In 2014 there were just over 23000 working fashion designers Most work fulltime with occasion overtime when deadlines lurk Those who work freelance can work odd hours especially when working under contract so that they can adjust their day to their clients schedules Fashion Designer Education Training Requirements It is recommended but not required to earn a bachelors degree in fashion design or fashion merchandising if you want to become a professional fashion designer The extremely talented and extremely dedicated individuals can start at the bottom as an assistant fashion designer and work their way up without a formal degree but most manufacturers design firms and apparel companies look for students with a bachelors degree in a fashionrelated field In a degree program students learn about art history textiles and fabrics graphic design art and design drawing knitwear fashion and design strategies and techniques that include computeraided design A formal degree program also allows aspiring designers to gain valuable experience before they enter the workforce through internships or apprenticeships And while earning a degree students are advised on how to build a wellrounded portfolio of their design work that usually helps showcase their creative and artistic ability and progress to potential employers Schools offering specific fashion design programs have increased as demand has increased According to the National Association of Schools of Art and Design there are more than 300 institutions that offer accredited degree programs in art and design with many providing specific degree programs in fashion design or fashion merchandising For those adventurous few there are dozens of certificate one and twoyear and full degree study abroad programs in fashion design Imagine rubbing elbows with professional designers in Italy or France Or if you would rather study fashion in more than one country there are multicultural fashion programs that take students everywhere from Paris and London to Milan and Florence These programs are designed to give students an overview of fashion from other cultures and learn from people outside the mainstream of US fashion In addition to a great education there are a number of skills all fashion designers need in order to succeed in this competitive field They include strong visualization skills and a good sense of business A competitive spirit a good eye for detail a complete understanding of color texture fabric etc strong drawing skills and creative and artistic abilities are all skills needed to excel in the world of fashion design

O O O O O B I B I O O O O O O O O O O O O O O O O O O B I O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B I O O O B I O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B I O O O O O O O O O O O O O O O O O O O O O O O O O O B I O O O O O O O O O B I O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B I O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B I O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B I O O O O O O O O O O O O O O O O O O O O O O O O O O O B I O O O O O O O O O O O O O O O B I O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O

fashion designer
transcending convention


When Does Creativity Peak Youth Middle Age or Old Age This article is from the archive of our partner When in life are we most creative Do we peak when we are young and energetic or old and experienced Its a question with which scientists and writers have long struggled For some reason novelists are often the principal subject of these studies of age and creativity Here are three very different takes all insightful and convincing in their own way We Peak Young The New York Times Sam Tanenhaus age 54 acknowledges an essential truth about fiction writers They often compose their best and most lasting work when they are young Theres something very misleading about the literary culture that looks at writers in their 30s and calls them budding or promising when in fact theyre peaking Kazuo Ishiguro told an interviewer last year Ishiguro 54 when he said this added that since the age of 30 he had been haunted by the realization that most of the great novels had been written by authors under 40 It is a mistake to assume that because they are young at least according to our cultures ever expanding notion of youth when 40 or even 50 is the new 30 they must be poised midway up Parnassus with higher achievements to come The trouble perhaps is that this definition of young writer which owes less to literary considerations than to the intersecting categories of sociology and marketing muddies our understanding of how truly original enduring fiction comes to be written Worse it threatens to infantilize our writers reducing them to the condition of permanent apprentices who grind steadily toward We Peak in Middle Age Science journalist Jonah Lehrer age 28 writes its hard to settle this argument using anecdotes Fortunately a psychologist at UCDavis Dean Simonton has assembled the historiometric data He finds that the vast majority of disciplines obey an inverted U curve of creativity The shape of the curve captures the steep rise and slow fall of individual creativity with performance peaking after a few years of work before it starts a slow gradual decline For instance Simonton has found that poets and physicists tend to produce their finest work in their late 20s while geologists biologists and novelists tend to peak much later often not until they reach late middle age Simonton argues that those disciplines with an intricate highly articulated body of domain knowledge such as physics chess and poetry tend to encourage youthful productivity In contrast fields that are more loosely defined in which the basic concepts are ambiguous and unclear examples include history literary criticism and biology lead to later peak productive ages It takes time to master the complexity we We Peak Old Sometimes The New Yorkers Malcolm Gladwell age 45 writes Genius in the popular conception is inextricably tied up with precocitydoing something truly creative were inclined to think requires the freshness and exuberance and energy of youth But thats all wrong he argues Some poets do their best work at the beginning of their careers Others do their best work decades later Fortytwo per cent of Frosts anthologized poems were written after the age of fifty For Williams its fortyfour per cent For Stevens its fortynine per cent Gladwell says creativity can be divided into two types conceptual and experimental Conceptual thinkers peak young but experimental thinkers peak old The This article is from the archive of our partner The Wire We want to hear what you think about this article Submit a letter to the editor or write to letterstheatlanticcom Max Fisher is a former writer and editor at The Atlantic

O O B I O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B I O O B O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O

creativity peak
sam tanenhaus
acknowledges